As an example, in triple damaging breast cancer (TNBC),twenty five and in hepatocellular carcinoma,26 DNA methylation profiles have assisted on the identification of distinctive subgroups with clinical relevance. Epigenetic ways have also served to the development of prognostic exams to evaluate the sensitivity of cancer cells to precise medicine